Fig. 5From: Circ_0058063 contributes to cisplatin-resistance of bladder cancer cells by upregulating B2M through acting as RNA sponges for miR-335-5pCirc_0058063 ablation promoted cisplatin-sensitivity of BC cells in vivo. A Xenograft tumors of mice with or without CDDP treatment (3 mg/kg, three times a week) at the end of the experiment. B, C Weight and Volume of tumors that developed in xenograft tumors. D The immunohistochemistry assay in xenografts from different groups. E The percentage of KI67 positive cells in xenografts from different groups. *P < 0.05Back to article page